NR1D2 and gastric cancer: NR1D1 and NR1D2 are transcription factors that bind ROREs and act as transcriptional repressors to inhibit the expression of BMAL1:CLOCK [314], underlining the importance of considering circadian rhythms in gastric cancer development and treatment [313].